Algeta schedules first quarter 2013 results presentation, webcast and conference call

Marketwired

OSLO, NORWAY--(Marketwired - May 7, 2013) - Algeta ASA (OSE: ALGETA), a company focused onthedevelopment of novel targeted cancer therapeutics, will announce its firstquarter 2013 results on Wednesday, 15 May 2013. A presentation by Algeta'ssenior management team to investors, analysts and the press will take placeinOslo at 10:00 CET.

The presentation will also be webcast live and can be accessedthroughwww.algeta.com where questions can also be submitted during thepresentation.

The presentation will take place at 10:00 CET at:

Shippingklubben
Haakon VIIs gate 1
0161 Oslo
Norway.

Algeta's senior management will also host an international conferencecall at14:30 CET/08:30 Eastern Time (US) (details below).

To participate in the conference call, please dial the appropriate numberbelowfive minutes prior to the call:

US: +1 877 423 0830
UK: +44 20 7153 9154
Norway: +47 21 06 61 13
Sweden: +46 8-506 443 86
Denmark: +45 32 71 42 62
Switzerland: +41 44 580 65 22

Participant pin code: 281404#

To access the replay, please dial:

US: +1 877 679 2989
UK: +44 20 3364 5196
Norway: +47 23 50 02 03
Sweden: +46 8-505 564 73

Conference reference: 346423#

A replay version of the conference call will also beavailable atwww.algeta.com.

The results report and the presentation will be available atwww.algeta.com inthe Investors section from 07:00 CET.

###

About Algeta

Algeta is a company focused on developing novel targeted therapies forpatientswith cancer based on its alpha-pharmaceutical platform. The Company isheadquartered in Oslo, Norway, and has a US subsidiary, Algeta US, LLC,based inCambridge, MA performing commercial marketing operations in the US. Algetaislisted on the Oslo Stock Exchange (ALGETA.OL). For more informationpleasevisit www.algeta.com.

Press release:http://hugin.info/134655/R/1699187/560422.pdf

This announcement is distributed by Thomson Reuters on behalf ofThomson Reuters clients. The owner of this announcement warrants that:

(i) the releases contained herein are protected by copyright and other applicable laws; and

(ii) they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Algeta ASA via Thomson Reuters ONE

[HUG#1699187]

Contact:
For further information, please contact:
Mike Booth / Renate Birkeli
Communications & Corporate Affairs
+47 23 00 67 32
Email Contact

Media enquiries:
Mark Swallow
Citigate Dewe Rogerson
+44 207 638 9571
Email Contact

Knut Ekern
Gambit Hill & Knowlton
+47 22 04 82 00
Email Contact

Kari Watson
MacDougall Biomedical Communications
+1 781 235 3060
Email Contact

US investor enquiries:
Tricia Swanson
The Trout Group
+1 646 378 2953
Email Contact

View Comments (0)